PATIENTS CAN ONLY CLAIM THEIR PAID CONTRIBUTION, NOT THEIR EXCESS
General information
The pharmacist has dispensed Adhesa® 5 mg to the patient. The health insurer will not reimburse the cost of…
Reimbursement Scheme Adhesa®
The health insurer does not fully reimburse Adhesa® 5 mg. The producer of this medicine has therefore asked TBR Nederland to reimburse the costs of the Personal…
Update Reimbursement Scheme Adempas®
As off May 31st 2023, the reimbursement for Adempas® 0.5 mg and 1.0 mg is now also indicated for the treatment of PAH in pediatric patients aged less than…
PATIENTS CAN ONLY CLAIM THEIR PAID CONTRIBUTION, NOT THEIR EXCESS
General information
The pharmacist has dispensed Adempas® 0.5 or 1mg to the patient. The health insurer will not…
General information
The pharmacist has dispensed PLENADREN® 5 or 20mg to you. The health insurer will not reimburse the cost of this prescription in full. The manufacturer of this medicine has…
General information
The pharmacist has dispensed Signifor® 20 mg to the patient. The health insurer will not reimburse the cost of this prescription in full. The producer of this medicine has…
General information
The pharmacist has dispensed ELVANSE® 20, 30, 40, 50, 60 or 70mg to the patient. The health insurer will not reimburse the cost of this prescription in full. The…
Reimbursement Scheme Jardiance® - Chronic Kidney Disease
Arrangement for reimbursement by TerugBetaalRegeling Jardiance® (empagliflozin) 10 mg for patients with chronic kidney disease without type 2…
At Phareso B.V., registered at Professor Bavincklaan 7, 1183 AT Amstelveen, The Netherlands and its Foundations, together trading as Terugbetaalregeling.nl, (“TBR, "we", "us") we respect your…
